| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 38 |
| 1 | PACLITAXEL | 32 |
| 2 | CISPLATIN | 26 |
| 3 | CARBOPLATIN | 23 |
| 4 | ADALIMUMAB | 8 |
| 5 | DENOSUMAB | 7 |
| 6 | LETROZOLE | 6 |
| 7 | LETROZOLE TABLETS | 6 |
| 8 | TOPOTECAN | 5 |
| 9 | ACETAMINOPHEN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PYRANTEL PAMOATE | 1 | 0.0217 |
| 1 | PRAZIQUANTEL | 1 | 0.0033 |
| 2 | PLATINUM | 1 | 0.0019 |
| 3 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 4 | TOPOTECAN | 5 | 0.0008 |
| 5 | METHYLNALTREXONE BROMIDE | 1 | 0.0007 |
| 6 | FELBAMATE | 1 | 0.0006 |
| 7 | SOLIFENACIN SUCCIATE | 1 | 0.0005 |
| 8 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 9 | TELMISARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Antiparasitic [EPC] | 1 | 0.0002 |
| 2 | Pediculicide [EPC] | 1 | 0.0002 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 38 | 0.0002 |
| 4 | Microtubule Inhibitor [EPC] | 33 | 0.0002 |
| 5 | Platinum-based Drug [EPC] | 45 | 0.0002 |
| 6 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 7 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 9 | Chloride Channel Activator [EPC] | 1 | 0.0001 |